Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M

巨噬细胞缺氧信号通过抑癌素M调节心脏纤维化

阅读:2
作者:Hajime Abe ,Norihiko Takeda ,Takayuki Isagawa ,Hiroaki Semba ,Satoshi Nishimura ,Masaki Suimye Morioka ,Yu Nakagama ,Tatsuyuki Sato ,Katsura Soma ,Katsuhiro Koyama ,Masaki Wake ,Manami Katoh ,Masataka Asagiri ,Michael L Neugent ,Jung-Whan Kim ,Christian Stockmann ,Tomo Yonezawa ,Ryo Inuzuka ,Yasushi Hirota ,Koji Maemura ,Takeshi Yamashita ,Kinya Otsu ,Ichiro Manabe ,Ryozo Nagai ,Issei Komuro

Abstract

The fibrogenic response in tissue-resident fibroblasts is determined by the balance between activation and repression signals from the tissue microenvironment. While the molecular pathways by which transforming growth factor-1 (TGF-β1) activates pro-fibrogenic mechanisms have been extensively studied and are recognized critical during fibrosis development, the factors regulating TGF-β1 signaling are poorly understood. Here we show that macrophage hypoxia signaling suppresses excessive fibrosis in a heart via oncostatin-m (OSM) secretion. During cardiac remodeling, Ly6Chi monocytes/macrophages accumulate in hypoxic areas through a hypoxia-inducible factor (HIF)-1α dependent manner and suppresses cardiac fibroblast activation. As an underlying molecular mechanism, we identify OSM, part of the interleukin 6 cytokine family, as a HIF-1α target gene, which directly inhibits the TGF-β1 mediated activation of cardiac fibroblasts through extracellular signal-regulated kinase 1/2-dependent phosphorylation of the SMAD linker region. These results demonstrate that macrophage hypoxia signaling regulates fibroblast activation through OSM secretion in vivo.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。